Catastrophic antiphospholipid syndrome: A rare cause of disseminated microvascular thrombotic injury - A case report with pathological and molecular correlative studies

Pathology International

Volumn 55, Issue 3, 2005, Pages 144-149

  Lai, Syeling ^a   Walker, David H ^a   Elghetany, M Tarek ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Antiphospholipid syndrome; Autopsy; Thrombophilia

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; HOMOCYSTEINE; IMMUNOSUPPRESSIVE AGENT; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S;

ACUTE KIDNEY FAILURE; ACUTE RESPIRATORY FAILURE; ADULT; ANTIBIOTIC THERAPY; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME; DOPPLER ECHOGRAPHY; FEMALE; FOOT PAIN; GANGRENE; GENE MUTATION; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; ILEUS; IMMUNOSUPPRESSIVE TREATMENT; LIMB ISCHEMIA; MULTIPLE ORGAN FAILURE; PLASMAPHERESIS; POLYMYOSITIS; PRIORITY JOURNAL; RETROPERITONEAL HEMATOMA; SKIN ULCER; THROMBOPHILIA; THROMBOSIS;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; CATASTROPHIC ILLNESS; FATAL OUTCOME; FEMALE; HUMANS; MICROCIRCULATION; MULTIPLE ORGAN FAILURE; SKIN; SKIN ULCER; THROMBOSIS;

EID: 16444373878     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2005.01798.x     Document Type: Article

References (26)

1. Bick RL. Antiphospholipid thrombosis syndromes. Hematol Oncol Clin North Am 2003; 17: 115-47.
2. Burcoglu-O'Ral A, Erkan D, Asherson R. Treatment of catastrophic antiphospholipid syndrome with defibrotide, a proposed vascular endothelial cell modulator. J Rheumatol 2002; 29: 2006-11.
3. Galli M, Finazzi G, Duca F, Norbis F, Moia M. G1691-A mutation of factor V, but not the G20210-A mutation of factor II or the C677-T mutation of methylene tetrahydrofolate reductase genes, is associated with venous thrombosis in patients with lupus anticoagulants. Br J Haematol 2002; 108: 865-70.
4. Lanir N, Zilberman M, Yron I, Tennenbaum G, Shechter Y, Brenner B. Reactivity patterns of antiphospholipid antibodies and endothelial cells: effect of antiendothelial antibodies on cell migration. J Lab Clin Med 1998; 131: 548-56.
5. Meroni PL, Raschi E, Testoni C. Endothelium as a target for anti-phospholipid antibodies and for therapeutical intervention. Autoimmune Rev 2002; 1: 55-60.
6. Topaloglu R, Akierli C, Bakkaloglu A et al. Survey of factor V Leiden and prothrombin gene mutations in systemic lupus erythematosus. Clin Rheumatol 2001; 20: 259-61.
7. Asherson R. The catastrophic antiphospholipid syndrome. J Rheumatol 1992; 19: 506-12.
8. Asherson RA, Cervera R, Piette J-C et al. Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine 2001; 80: 355-77.
9. Bravo-Osorio M, Bydlowski SP. Detection of methylenetetrahydrofolate reductase (MTHFR) C677T and prothrombin G20210A mutations: second restriction site for digestion control of PCR products. Clin Chim Acta 2000; 301: 219-23.
10. de Ronde H, Bertina RM. Laboratory diagnosis of APC-resistance: a critical evaluation of the test and the development of diagnostic criteria. Thromb Haemost 1994; 72: 880-86.
11. Vila P, Hernandez MC, Lopez-Fernandez MF, Battle J. Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects. Thromb Haemost 1994; 72: 209-13.
12. Sherer Y, Livneh A, Levy Y et al. Dermatomyositis and polymyositis associated with the antiphospholipid syndrome - a novel overlap syndrome. Lupus 2000; 9: 42-6.
13. Asherson RA, Cervera R, de Groot PG et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 2003; 12; 530-34.
14. Amigo MC, Garcia-Torres R. Morphology of vascular, renal, and heart lesions in the antiphospholipid syndrome: relationship to pathogenesis. Curr Rheumatol Rep 2000; 2: 262-70.
15. Mizuno R, Fujimoto S, Fujimoto T et al. Catastrophic antiphospholipid antibody syndrome in systemic lupus erythematosus: an autopsy case report of a young woman. Intern Med 2000; 39: 856-9.
16. Shames DS, Broderick PA. Catastrophic antiphospholipid antibody syndrome. Connecticut Med 2001; 65: 3-5.
17. Vaphiades MS, Brock W, Brown HH, Petursson G, Westfall CT. Catastrophic antiphospholipid antibody syndrome manifesting as an orbital ischemia syndrome. J Neuro-Opthalmol 2001; 21: 260-63.
18. Gharavi E, Cucurull E, Tang E, Celli CM, Wilson WA, Gharavi AE. Induction of antiphospholipid antibodies by immunization with viral peptides. Lupus 1999; 8: 449-55.
19. Cervera R, Asherson RA, Acevedo ML et al. Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients. Ann Rheum Dis 2004; 63: 1312-17.
20. Gharavi AE, Pierangeli SS, Harris N. New developments in viral peptides and APL induction. J Autoimmun 2000; 15: 227-30.
21. Erkan D, Cervera R, Asherson RA. Catastrophic antiphospholipid syndrome: where do we stand? Arthritis Rheum 2003; 48: 3320-27.
22. Flamholz R, Tran T, Grad GI et al. Therapeutic plasma exchange for the acute management of the catastrophic antiphospholipid antibody syndrome: β(2)-glycoprotein I antibodies as a marker of response to therapy. J Clin Apheresis 1999; 14: 171-6.
23. Higginbotham EA, Zimmerman SA, Howard TA, Schanberg L, Kredich D, Ware R. Effects of inherited thrombophilic mutations in an adolescent with antiphospholipid syndrome and systemic lupus erythematosus. J Rheumatol 2001; 28: 370-72.
24. Chopra N, Koren S, Greer WL et al. FactorV Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies. J Rheumatol 2002; 29: 1683-8.
25. Hartnett EM, Laposata M, Van Cott E. Antiphospholipid antibody syndrome in a six-year-old female patient. Am J Ophthalmol 2003; 135: 542-4.
26. Wu L, Patten N, Yamashiro CT, Chui B. Extraction and amplification of DNA from formalin-fixed, paraffin-embedded tissues. Appl Immunohistochem Mol Morphol 2002; 10: 269-74.